Medipal Holdings Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
81,844.00
76,734.00
74,741.00
70,061.00
57,284.00
49,237.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-9,356.00
-4,868.00
4,981.00
-35,376.00
36.00
-6,764.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
49,453.00
60,559.00
61,843.00
16,146.00
61,216.00
34,448.00
Cash Flow from Investing Activities
6,398.00
-3,363.00
-7,817.00
-39,474.00
-24,343.00
-2,939.00
Cash Flow from Financing Activities
-29,397.00
-25,947.00
-25,248.00
-43,561.00
-16,471.00
-16,003.00
Net Cash Inflow / Outflow
26,460.00
31,252.00
28,778.00
-66,889.00
20,402.00
15,506.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
6.00
3.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Medipal Holdings Corp.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
81844
62007
19,837.00
31.99%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-9356
-2072
-7,284.00
-351.54%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
49453
38566
10,887.00
28.23%
Cash Flow from Investing Activities
6398
-8721
15,119.00
173.36%
Cash Flow from Financing Activities
-29397
-14047
-15,350.00
-109.28%
Net Cash Inflow / Outflow
26460
15841
10,619.00
67.03%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
6
43
-37.00
-86.05%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -18.34% vs -2.08% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
49,453.00
60,559.00
-18.34%






